Dual Action Pain Relief Tablet
Product Images NDC 11673-924

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dual Action Pain Relief (NDC 11673-924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

716r-target-ibupara-72ct-ifc (716r Target Ibupara 72ct Ifc)

Dual Action Pain Relief acetaminophen 250 mg and ibuprofen (NSAID) 125 mg tablets packaging label from Target Corporation. The label shows 72 caplets, describes the product as a pain reliever, and includes a comparison to Advil Dual Action with Acetaminophen Caplets. The package displays the up&up logo, actual caplet size graphic, warnings, drug facts, and directions.*

FDA Label Image

716r-target-ibupara-72ct-ifc (716r Target Ibupara 72ct Label)

Dual Action Pain Relief acetaminophen and ibuprofen (NSAID) tablets, 250 mg/125 mg, oral tablet dosage form. The label from Target Corporation indicates the package contains 72 caplets (capsule-shaped tablets). The label also includes warnings and usage information about the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.